Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APISIA: Platelet Function Testing for Ischemic Event Prevention
NCT03989557Phase 4Completed
- Sponsor
- Beijing Neurosurgical Institute
- Start
- Jul 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in thromboembolism, sponsored by Beijing Neurosurgical Institute. Started Jul 2019; status: completed.
02
Drugs
ticagrelor
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT03989557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03989557.